Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502562526

AdipoGen Salinosporamide A
SDP

Catalog No. 502562526
Encompass_Preferred

Chemical. CAS 437742-34-2. Formula C15H20ClNO4. MW 313.8. Isolated from Salinospora tropica. Potent, irreversible inhibitor of all the 3 proteolytic activities of the mammalian 20S proteasome. beta5 subunit chymotrypsin-like EC50 = 3.5nM beta2 subunit trypsin-like EC50 = 28nM beta1 subunit caspase-like or peptidyl-glutamyl peptide-hydrolyzing PGPH EC50 = 430nM Potent anticancer compound. Triggers apoptosis, with distinct proteasome activity and mechanism of action compared to bortezomib Velcade Prod. No. AG-CR1-3602. Most potent suppressor of NF-kappaB activation, compared with bortezomib, MG-132 Prod. No. AG-CP3-0011, N-acetyl-leucyl-leucyl-norleucinal ALLN and lactacystin Prod. No. AG-CN2-0104. Inhibitor of TNF-alpha, IL-1, IL-6, ICAM-1 and VEGF synthesis. Displays a longer inhibition duration than bortezomib. Potent antileukemic activity against bortezomib-resistant leukemia cells.

Catalog No. 50-256-2526 Supplier AdipoGen Supplier No. AGCN20444C100
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Chemical. CAS 437742-34-2. Formula C15H20ClNO4. MW 313.8. Isolated from Salinospora tropica. Potent, irreversible inhibitor of all the 3 proteolytic activities of the mammalian 20S proteasome. beta5 subunit chymotrypsin-like EC50 = 3.5nM beta2 subunit trypsin-like EC50 = 28nM beta1 subunit caspase-like or peptidyl-glutamyl peptide-hydrolyzing PGPH EC50 = 430nM Potent anticancer compound. Triggers apoptosis, with distinct proteasome activity and mechanism of action compared to bortezomib Velcade Prod. No. AG-CR1-3602. Most potent suppressor of NF-kappaB activation, compared with bortezomib, MG-132 Prod. No. AG-CP3-0011, N-acetyl-leucyl-leucyl-norleucinal ALLN and lactacystin Prod. No. AG-CN2-0104. Inhibitor of TNF-alpha, IL-1, IL-6, ICAM-1 and VEGF synthesis. Displays a longer inhibition duration than bortezomib. Potent antileukemic activity against bortezomib-resistant leukemia cells.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.